PRECIPIO, INC. Deferred Tax Assets, Operating Loss Carryforwards
PRECIPIO, INC. (PRPO) had Deferred Tax Assets, Operating Loss Carryforwards of $68.00 million as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2021-03-29
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards $68.00M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards $61.00M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards $61.00M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.00M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2020-12-31 | $68.00M 10-K · filed 2021-03-29 | |
| 2019-12-31 | $61.00M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $61.00M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $39.00M 10-K · filed 2020-03-27 | |
| 2016-12-31 | $60.28M 10-K · filed 2017-04-13 | |
| 2015-12-31 | $51.45M 10-K · filed 2017-04-13 | |
| 2014-12-31 | $46.05M 10-K · filed 2016-04-14 | $46.23M 10-K · filed 2015-04-15 |
| 2013-12-31 | $42.95M 10-K · filed 2015-04-15 | |
| 2012-12-31 | $39.48M 10-K · filed 2014-03-27 | |
| 2011-12-31 | $38.15M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |